McKesson Europe AG (McKesson Europe AG) EBIT : $-22 Mil (TTM As of Mar. 2022)

View and export this data going back to 2008. Start your Free Trial

What is McKesson Europe AG EBIT?

McKesson Europe AG's earnings before interest and taxes (EBIT) for the six months ended in Mar. 2022 was $-22 Mil. Its earnings before interest and taxes (EBIT) for the trailing twelve months (TTM) ended in Mar. 2022 was $-22 Mil.

EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition. McKesson Europe AG's annualized ROC % for the quarter that ended in Mar. 2022 was 1.10%. McKesson Europe AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was -0.95%.

EBIT is also linked to Joel Greenblatt's definition of earnings yield. McKesson Europe AG's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Mar. 2022 was -0.52%.

McKesson Europe AG EBIT Historical Data

The historical data trend for McKesson Europe AG's EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

McKesson Europe AG EBIT Chart

McKesson Europe AG Annual Data

Trend

Dec12

Dec13

Dec14

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

EBIT

Get a 7-Day Free Trial

-310.85

50.17

19.67

43.93

-21.59

McKesson Europe AG Semi-Annual Data
	Dec02	Dec03	Dec04	Dec05	Dec06	Dec07	Dec08	Dec09	Dec10	Dec11	Dec12	Dec13	Dec14	Mar16	Mar17	Mar18	Mar19	Mar20	Mar21	Mar22
EBIT	Get a 7-Day Free Trial															-310.85	50.17	19.67	43.93	-21.59

Competitive Comparison of McKesson Europe AG's EBIT

For the Medical Distribution subindustry, McKesson Europe AG's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

McKesson Europe AG's EV-to-EBIT Distribution in the Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, McKesson Europe AG's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where McKesson Europe AG's EV-to-EBIT falls into.

McKesson Europe AG EBIT Calculation

EBIT, sometimes also called Earnings Before Interest and Taxes, is a measure of a firm's profit that includes all expenses except interest and income tax expenses. It is the difference between operating revenues and operating expenses. When a firm does not have non-operating income, then Operating Income is sometimes used as a synonym for EBIT and operating profit.

For stock reported annually, GuruFocus uses latest annual data as the TTM data. EBIT for the trailing twelve months (TTM) ended in Mar. 2022 was $-22 Mil.

McKesson Europe AG (OTCPK:CAKFY) EBIT Explanation

1. EBIT or Operating Income is linked to Return on Capital for both regular definition and Joel Greenblatt's definition.

McKesson Europe AG's annualized ROC % for the quarter that ended in Mar. 2022 is calculated as:

	ROC % (Q: Mar. 2022 )
=	NOPAT	/	Average Invested Capital
=	Operating Income * ( 1 - Tax Rate % )	/	( (Invested Capital (Q: Mar. 2021 )	+	Invested Capital (Q: Mar. 2022 ))	/ count )
=	33.811 * ( 1 - -40.74% )	/	( (4545.477	+	4075.441)	/ 2 )
=	47.5856014	/	4310.459
=	1.10 %

where

	Invested Capital		(Q: Mar. 2021 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	8389.643	-	3618.214	-	( 225.952	-	max(0, 4645.595	-	5836.429	+	225.952	))
=	4545.477

	Invested Capital		(Q: Mar. 2022 )
=	Total Assets	-	Accounts Payable & Accrued Expense	-	Excess Cash
=	Total Assets	-	Accounts Payable & Accrued Expense	-	( Cash, Cash Equivalents, Marketable Securities	-	max(0, Total Current Liabilities	-	Total Current Assets	+	Cash, Cash Equivalents, Marketable Securities	))
=	5619.053	-	1537.775	-	( 5.837	-	max(0, 2508.59	-	4570.485	+	5.837	))
=	4075.441

Note: The Operating Income data used here is one times the annual (Mar. 2022) data.

2. Joel Greenblatt's definition of Return on Capital:

McKesson Europe AG's annualized ROC (Joel Greenblatt) % for the quarter that ended in Mar. 2022 is calculated as:

	ROC (Joel Greenblatt) %		(Q: Mar. 2022 )
=	EBIT	/	Average of (Net fixed Assets	+	Net Working Capital)
=	EBIT	/	Average of (Property, Plant and Equipment	+	Net Working Capital)
			Q: Mar. 2021		Q: Mar. 2022
=	EBIT	/	( ( (Property, Plant and Equipment + Net Working Capital)	+	(Property, Plant and Equipment + Net Working Capital) )	/	count )
=	-21.586	/	( ( (984.643 + max(1063.691, 0))	+	(396.035 + max(2090.75, 0)) )	/	2 )
=	-21.586	/	( ( 2048.334	+	2486.785 )	/	2 )
=	-21.586	/	2267.5595
=	-0.95 %

where Working Capital is:

	Working Capital		(Q: Mar. 2021 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(2248.69	+	1487.381	+	1871.191)	-	(3618.214	+	0	+	925.357)
=	1063.691

	Working Capital		(Q: Mar. 2022 )
=	(Accounts Receivable	+	Total Inventories	+	Other Current Assets)	-	(Accounts Payable & Accrued Expense	+	Defer. Rev.	+	Other Current Liabilities)
=	(1017.181	+	642.291	+	2905.176)	-	(1537.775	+	0	+	936.123)
=	2090.75

When net working capital is negative, 0 is used.

Note: The EBIT data used here is one times the annual (Mar. 2022) EBIT data.

3. It is also linked to Joel Greenblatt's definition of Earnings Yield:

McKesson Europe AG's Earnings Yield (Joel Greenblatt) % for today is calculated as:

Earnings Yield (Joel Greenblatt) %	=	EBIT (TTM)	/	Enterprise Value (Q: Mar. 2022 )
	=	-21.586	/	4166.010
	=	-0.52 %

McKesson Europe AG EBIT Related Terms

Thank you for viewing the detailed overview of McKesson Europe AG's EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.

McKesson Europe AG (McKesson Europe AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » McKesson Europe AG (OTCPK:CAKFY) » Definitions » EBIT

Comparable Companies

Traded in Other Exchanges

N/A

Address

Stockholmer Platz 1, Stuttgart, BW, DEU, 70137

Website

https://www.mckesson.eu

McKesson Europe AG is a medical care company that provides logistics and services to the pharmaceutical and healthcare sectors. The company operates two distinct segments: Pharmaceutical Distribution and Retail Pharmacy. The Pharmaceutical Distribution business sells wholesale pharmaceutical products and generates the majority of the company's revenue. The Retail Pharmacy segment operates its own pharmacies in addition to franchise pharmacies that provide prescriptions and over-the-counter pharmaceutical products. Geographically, the company's revenue derives predominantly from the United Kingdom, France, Germany, and other countries.

McKesson Europe AG (McKesson Europe AG) Headlines

No Headlines